Old Web
English
Sign In
Acemap
>
Paper
>
The candidate HCV E1E2MF59 vaccine enhances 2nd phase viral decline in responders to PEG-IFN/ribavirin
The candidate HCV E1E2MF59 vaccine enhances 2nd phase viral decline in responders to PEG-IFN/ribavirin
2009
P. Colombatto
Maurizia Rossana Brunetto
A.M. Maina
V. Romagnoli
A. Craxì
P.L. Almasio
S. Madonia
M.G. Rumi
M. Colombo
S. Fargion
A. Ascione
G. Pinzello
Mario U. Mondelli
A. Muzzi
F.B. Bianchi
Vincenzo Barnaba
M. Sarracino
Rino Rappuoli
Domenico Rosa
S. Montigiani
Sergio Abrignani
Michael Houghton
Ferruccio Bonino
Keywords:
PEG ratio
Ribavirin
Virology
Medicine
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]